Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab (Vol 13, 973448, 2022)

被引：0
|
作者：
Frontiers Prod Off [1 ]
机构：
[1] Frontiers Media SA, Lausanne, Switzerland
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
关键词：
anlotinib; non-small cell lung cancer (NSCLC); bevacizumab; efficacy; safety;
D O I：
10.3389/fphar.2022.1092147
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety Evaluations of Anlotinib in Patients with Advanced Non-small Cell Lung Cancer Treated with Bevacizumab
    Jiang, F.
    Li, J.
    Kong, X.
    Qu, H.
    Sun, P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S436 - S436
  • [2] Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab
    Jiang, Fenge
    Li, Junxia
    Kong, Xiangshuo
    Sun, Ping
    Qu, Huajun
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer
    Zhong, Yuejiao
    Wei, Qiang
    Lu, You
    Tang, Xiuliang
    Wang, Zhongqiu
    Chen, Lingxiang
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6016 - 6022
  • [4] The Efficacy and Safety of Apatinib and Anlotinib in Advanced Non-Small Cell Lung Cancer
    Wei, Xiao
    Zhao, Yun
    Yan, Wenyue
    Dai, Qigang
    Wu, Hui
    Miao, Yang
    Huang, Lei
    Liu, Qing
    Zhang, Xuyao
    Wang, Hongxia
    Liu, Yanan
    Zhang, Linlin
    [J]. ONCOTARGETS AND THERAPY, 2024, 17 : 629 - 642
  • [5] Safety and efficacy of bevacizumab in "fragile" patients with advanced non-small cell lung cancer
    Maragkos, C.
    Grapsa, D.
    Koumakis, G.
    Polyzos, A.
    Syrigos, K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] Efficacy, safety, and prognostic factors of anlotinib treatment in advanced non-small cell lung cancer patients
    Huang, Aimi
    Wang, Weimin
    Qin, Ruoyan
    Chen, Guojie
    Gu, Aiqin
    Han, Baohui
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (05) : 1299 - +
  • [7] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Fen Wang
    Feng Jin
    Boran Cheng
    Yue Zhang
    Qing Zhou
    Shubin Wang
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 1721 - 1735
  • [8] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
  • [9] Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhong, Qiuxia
    Liu, Zhihua
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4115 - 4128
  • [10] Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer
    Lilenbaum, Rogerio
    Raez, Luis
    Tseng, Jennifer
    Seigel, Leonard
    Davila, Enrique
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (05) : 511 - 515
12345